Zdrowie i gospodarka · 26/06/2026

FDA Classifies SARS-CoV-2 Serology Test into Class II with Special Controls

The FDA has classified the SARS-CoV-2 serology test into Class II, a designation that will provide reasonable assurance of safety and effectiveness, while also reducing regulatory burdens and enhancing patient access to innovative devices.